Lipid vesicles that bind to anti-FSTL1 antibodies may have significant application prospects in the treatment of gliomas. By targeting tumor cells that express FSTL1, these lipid vesicles can achieve more efficient drug delivery while reducing damage to normal brain tissue. Such carriers help enhance drug bioavailability and improve anti-tumor effects. Future research may focus on in-depth assessments of their safety, efficacy, and clinical applications.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
BRD-0208MZ | Chicken Anti-FSTL1 Polyclonal IgY | WB | Chicken antibody |
There are currently no Customer reviews or questions for VS-1024-FY99. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.